ACRO BIOMEDICAL CO., LTD. (ACBM) Net margin 2017–2022
ACRO BIOMEDICAL CO., LTD. (ACBM) net profit margin by fiscal year — reported net income divided by reported revenue.
-2410.2%FY2022 · since FY2017: -0.4% → -2410.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -2410.2% | -1767.4 pp |
| FY2021 | -642.8% | -625.8 pp |
| FY2020 | -17.1% | +174.9 pp |
| FY2019 | -192.0% | -197.2 pp |
| FY2018 | 5.2% | +5.7 pp |
| FY2017 | -0.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice